DrugDashboards

Ibuprofen

Ibupfrofen · IBUPROFEN 200 mg/1 · Tablet, Film Coated · Oral · Time Cap Laboratories,inc

NDC 49483-0600-01 · 100 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Regulatory

Application
ANDA091239
TE code
Approval date
Feb 1, 2011
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class II · TerminatedJan 11, 2018
    Time-Cap Laboratories, Inc.CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
  • Class II · TerminatedJan 11, 2018
    Time-Cap Laboratories, Inc.CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Manufacturers of Ibupfrofen (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
Time Cap Laboratories,incIBUPROFEN 200 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Ibuprofen — NDC 49483-0600-01," retrieved September 3, 2026, https://drugdashboards.com/drug/49483060001.

Free to cite with attribution — see how the data is put together.